Canada markets close in 19 minutes

Prelude Therapeutics Incorporated (PRLD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.9600+0.2300 (+6.17%)
As of 01:56PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
92,198
103,393
92,889
86,778
48,177
Selling General and Administrative
30,967
28,884
30,651
26,957
10,586
Total Operating Expenses
123,165
132,277
123,540
113,735
58,763
Operating Income or Loss
-123,165
-132,277
-123,540
-113,735
-58,763
Total Other Income/Expenses Net
3,526
10,445
8,102
2,041
1,834
Income Before Tax
-119,639
-121,832
-115,438
-111,694
-56,929
Income from Continuing Operations
-119,639
-121,832
-115,438
-111,694
-56,929
Net Income
-119,639
-121,832
-115,438
-111,694
-56,929
Net Income available to common shareholders
-119,639
-121,832
-115,438
-111,694
-56,929
Basic EPS
-2.15
-
-2.44
-2.43
-4.56
Diluted EPS
-2.15
-
-2.44
-2.43
-4.56
Basic Average Shares
54,881
-
47,372
46,050
12,478
Diluted Average Shares
54,881
-
47,372
46,050
12,478